FDA Draft Guidance Urges Consistency, Plain Language In Combo Product Instructions
Executive Summary
A new draft guidance document from the US agency offers nuts-and-bolts guidance on formatting Instructions for Use (IFUs) for drug-device and biologic-device combination product applications.
You may also be interested in...
US FDA Guidance On Patient Labeling Leaves Unanswered Questions For Combination Products
Final guidance does not address recommendations raised by PhRMA and others about product descriptions and incorporating human outcome factors in instructions for use.
US FDA Guidance On Patient Labeling Leaves Unanswered Questions For Combination Products
Final guidance does not address recommendations raised by PhRMA and others about product descriptions and incorporating human outcome factors in instructions for use.
More Talk, Less Work: US FDA Outlines Expectations For Combo Products Discussions
New FDA draft guidance says manufacturers of combination products should first review existing combination product guidances and submit questions before asking for a combination product agreement meeting with regulators to get clarification. The guidance outlines what is expected of both sides in such meetings.